metformin has been researched along with epalrestat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, H; Fan, Z; Lei, Y; Li, L; Liu, W; Ma, B; Ma, Z; Xu, L; Yin, Z; Zhang, X; Zhu, C | 1 |
| Chen, H; Lei, Y; Liu, W; Ma, B; Xu, H; Xu, L; Zhang, X; Zhu, C | 1 |
3 other study(ies) available for metformin and epalrestat
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Multifunctional agents based on benzoxazolone as promising therapeutic drugs for diabetic nephropathy.
Topics: Aldehyde Reductase; Animals; Antioxidants; Benzoxazoles; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; HEK293 Cells; Humans; Hypoglycemic Agents; Mice; Molecular Docking Simulation; Molecular Structure; Protein Binding; Structure-Activity Relationship | 2021 |
Novel Hydroxychalcone-Based Dual Inhibitors of Aldose Reductase and α-Glucosidase as Potential Therapeutic Agents against Diabetes Mellitus and Its Complications.
Topics: Aldehyde Reductase; alpha-Glucosidases; Animals; Antioxidants; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glucose; Hypoglycemic Agents; Rats | 2022 |